Nisa Investment Advisors
CLYM

Nisa Investment Advisors’s Climb Bio CLYM Stock Holding History

Nisa Investment Advisors’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.92K Hold
573
– – ﹤0.01% 2511
2025
Q4 		$2.29K Hold
573
– – ﹤0.01% 2588
2025
Q3 		$1.15K Hold
573
– – ﹤0.01% 2715
2025
Q2 		$711 Buy
+573
New +$713 ﹤0.01% 2806
2025
Q1 		– Sell
-227
Closed -$409 – 3071
2024
Q4 		$409 Buy
+227
New +$821 ﹤0.01% 2865

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Nisa Investment Advisors's CLYM Position: Q1 2026 in Review

Nisa Investment Advisors held its Climb Bio (CLYM) position steady in Q1 2026 at 573 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Nisa Investment Advisors first reported a position in CLYM in Q4 2024 and has held it in 5 quarters since. 80 funds tracked by Wall St. Rank hold CLYM as of Q1 2026.

  • Nisa Investment Advisors held 573 shares of Climb Bio worth $3.92K as of Q1 2026.
  • Nisa Investment Advisors left its Climb Bio share count unchanged in Q1 2026.
  • Climb Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2511 holding.
  • Nisa Investment Advisors first reported a position in Climb Bio in Q4 2024 and has held it in 5 quarters since.
  • 80 funds tracked by Wall St. Rank held Climb Bio as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.